OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.
Alimera Sciences, Inc. (NASDAQ: ALIM) surged to a 52-week high of 3.98 on Monday, this after closing Friday’s trading session at 3.11, while volume in the biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals … Continue reading →
Posted in Articles, NASDAQ
|
Tagged alim, alimera sciences, biopharmaceutical, diabetes, diabetic, dme, fda, iluvien, investors, pdufa
|
Trading volume in Lexicon Pharmaceuticals (NASDAQ: LXRX) spiked on Monday, closing the last trading day of 2012 with more than 6.7 million shares moving hands while the share price of the biopharmaceutical company, which focuses on discovering breakthrough treatments for … Continue reading →
Shareholders of Cardium Therapeutics (AMEX: CXM) have endured a lot over the years, waiting patiently for the day when the biotechnology company would gain FDA approval for a product and begin generating meaningful revenue. In October 2011 CXM received that … Continue reading →
Posted in AMEX, Articles, Penny Stocks
|
Tagged biotechnology, cardium therapeutics, cxm, diabetes, fda, investors, penny stocks, pharmaceutical, wound care
|
When, if ever, will Generex Biotechnology Corporation (OTCBB: GNBT) transition from a company with the potential to earn significant revenue to a company that actually generates significant revenue? This is the question every shareholder of GNBT has been asking for … Continue reading →
Backed by news that the FDA approved clearance for their mobile health system for diabetes management, iglucose, shares of PositiveID Corporation (OTCBB: PSID) have jumped more than 36% during Wednesday’s trading session, hitting a high of 0.298 with volume surpassing … Continue reading →
Cardium Therapeutics (AMEX: CXM) has been battling for nearly two years to receive 510(k) clearance from the FDA to market and sell their Excellagen professional-use, sterile, syringe-based advanced wound care product for the management of diabetic foot ulcers and other … Continue reading →
Posted in AMEX, Articles, Penny Stocks
|
Tagged amex, biomedical, cardium, cxm, dfu, diabetes, diabetic foot ulcers, excellagen, fda, investors, penny stocks
|
While the moral debate concerning the use of human embryonic stem cells (hESCs) as the foundation for regenerative medicine remains as heated as ever there are few who question the legitimate medical benefits of the controversial subject. With so much … Continue reading →
Shareholders of Generex Biotechnology, Inc. (OTCBB: GNBT) have been banking on the company’s potential for some time, often relying on that potential to carry them through some disappointing setbacks and financial uncertainty, but how much longer can investors gamble on … Continue reading →
Posted in Articles, OTC Bulletin Board, Penny Stocks
|
Tagged amarantus, ambs, breast cancer, cancer, diabetes, drug, generex biotechnology, gnbt, investors, oral-lyn, otcbb, penny stocks, rapidmist
|
During times like this it’s difficult to find anything positive in the events that have unfolded, no matter how deep you dig looking for that nugget of hope or how artful you are in spinning a story of redemption XOMA … Continue reading →
Posted in Articles, NASDAQ, Penny Stocks, Small Cap
|
Tagged biotech, diabetes, diabetes treatment, engle, fda approval, investors, NASDAQ, penny stocks, xoma, xoma 052
|
With the debate over the proposed reverse stock split still raging and their Phase III trial of Oral-lyn now several months behind schedule the future of Generex Biotechnology Corporation (OTCBB: GNBT) appears to be up in the air. While the … Continue reading →
Posted in Articles, OTC Bulletin Board
|
Tagged biotechnology, diabetes, drug delivery system, generex biotechnology, gnbt, investors, NASDAQ, oral-lyn, otcbb, penny stocks, reverse stock split
|
